---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008898"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:31:33.532671+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Coherus stockholders elect directors, approve say-on-pay and equity plan amendment

## Summary
- Elected Class I directors: Newcomer (48.3M for), Newton (47.2M for), Tzoumakas (46.1M for).
- Ratified Ernst & Young as auditor for FY2024 with 79.8M for, 552K against.
- Advisory say-on-pay approved (40.3M for, 16.5M against, 1.8M abstain).
- Restated 2014 Equity Incentive Award Plan approved (37.6M for, 18.9M against).

## SEC filing metadata
- accession: 0001558370-24-008898
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000155837024008898/0001558370-24-008898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024008898/chrs-20240529x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008898
- JSON: https://secwatch.observer/filing/0001558370-24-008898.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008898.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.